🇺🇸 FDA
Pipeline program

Stereotactic Radiation Therapy

GTM-102

Phase 3 other active

Quick answer

Stereotactic Radiation Therapy for Brain Metastases is a Phase 3 program (other) at GT Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
GT Biopharma
Indication
Brain Metastases
Phase
Phase 3
Modality
other
Status
active

Clinical trials